Physician profile
Timothy John Minton
NPI 1205086931
$3,289.32
in general payments reported to CMS, 2019-2025
21 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $440 · 2021: $1,159 · 2022: $440 · 2023: $363 · 2024: $246 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $841.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $1,129.61 | 2019-2025 | |
| Organogenesis INC. | $813.07 | 2020-2023 | Puraply |
| Integra Lifesciences Corporation | $240.92 | 2020-2022 | |
| Merz North America, INC. | $182.72 | 2021-2023 | Xeomin |
| Access Pro Medical, LLC | $130.78 | 2022 | |
| Abbvie INC. | $129.27 | 2023-2024 | |
| Polynovo North America LLC | $100.00 | 2023 | |
| Acclarent, INC | $94.21 | 2019 | |
| Optinose US, INC. | $78.55 | 2019-2021 | |
| Glaxosmithkline, LLC. | $73.38 | 2021-2023 | Nucala |
| Regeneron Healthcare Solutions, INC. | $57.89 | 2020-2023 | Dupixent |
| Smith+Nephew, INC. | $43.52 | 2019-2023 | Stravix |
| Allergan, INC. | $42.87 | 2019-2020 | |
| Intersect Ent, INC. | $29.16 | 2021 | |
| W. L. Gore & Associates, INC. | $28.08 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $27.02 | 2022 | |
| Baxter Healthcare | $23.93 | 2021 | |
| Novo Nordisk INC | $21.67 | 2024 | Ozempic |
| Zimmer Biomet Holdings, INC. | $15.91 | 2021 | |
| Acacia Pharma INC | $13.65 | 2022 | |
| Acera Surgical, INC. | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Minton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.